Friday, June 23, 2017

BIONEXT LAUNCHES BIOSIGHT: AN ONLINE PLATFORM THAT WILL REVOLUTIONIZE PHARMACEUTICAL RESEARCH

Helps companies accelerate the development of new medications by reducing the failure rate during the clinical phase

STRASBOURG, France, June 22 (Bernama-BUSINESS WIRE) -- Bionext, a bioinformatics company, announces today the launch of BioSight, an online bio-simulation platform designed for efficient identification of possible side effects of potential drug treatments on the human body. As result of fifteen years of molecular biology R&D, BioSight uses a patented algorithm that is able to predict all of the potential biological targets that are at risk of interacting with a potential drug treatment. Available as Software as a Service (SaaS) or on-site, BioSight, at an affordable price and within a few hours, enables pharmaceutical and biomedical research professionals to better develop their molecules, reduce the failure rate during the clinical trial phase and, therefore, optimize their return on investment.
http://mrem.bernama.com/viewsm.php?idm=29418

No comments:

Post a Comment